Search Within

Debyani Chakravarty

Formats
  1. Journal Article (48)
  2. Meeting Abstract (26)
  3. Review (7)
  4. Guidelines (3)
  5. Editorial (2)
  6. Book Section (1)
  7. Correspondence (1)
Groups
  1. Department of Pathology and Laboratory Medicine (88)
  2. GSK Faculty (66)
  3. Department of Medicine (65)
  4. Human Oncology and Pathogenesis Program (64)
  5. Solid Tumor Oncology Division (60)
  6. Center for Molecular Imaging and Biotechnology (CMIB) (54)

More Groups

People
  1. Michael Berger (43)
  2. Nikolaus Schultz (42)
  3. David Solit (40)
  4. Marc Ladanyi (39)
  5. Ahmet Zehir (29)
  6. Jianjiong Gao (28)

More People

Years
  1. 2025 (5)
  2. 2024 (11)
  3. 2023 (7)
  4. 2022 (18)
  5. 2021 (6)
  6. 2020 (9)

More Years

Publications
  1. Cancer Discovery (11)
  2. Cancer Research (11)
  3. Journal of Clinical Oncology (11)
  4. Annals of Oncology (5)
  5. Cell (4)
  6. JCO Precision Oncology (4)

More Publications

Publishers
  1. American Association for Cancer Research (25)
  2. American Society of Clinical Oncology (17)
  3. Nature Publishing Group (16)
  4. Oxford University Press (8)
  5. Cell Press (5)
  6. Elsevier Science, Inc. (4)

More Publishers

Results (88)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Next generation sequencing (NGS) in lung adenocarcinoma (LA) as a guide to treatment selection
    Meeting Abstract

    Jordan, E.; Barron, D.; Schultz, N.; Chakravarty, D.; Kris, M. G.; Rudin, C. M.; Li, B. T.; Yu, H. A.; Drilon, A. E.; Rusch, V. W.; more...
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • OncoKB: Annotation of the oncogenic effect and treatment implications of somatic mutations in cancer
    Meeting Abstract

    Chakravarty, D.; Phillips, S. M.; Gao, J.; Kundra, R.; Zhang, H.; Rudolph, J. E.; Yaeger, R. D.; Soumerai, T.; Nissan, M. H.; Chandarlapaty, S.; more...
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • Role of intratumoral cell heterogeneity on therapeutic efficacy in glioblastoma
    Meeting Abstract

    Chakravarty, D.; Pedraza, A.; Liu, A. H.; Cotari, J. ; Altan-Bonnet, G.; Brennan, C. W.
    Cancer Research (2013)

    Fulltext@MSK | Save
  • The somatic genomic landscape of glioblastoma
    Journal Article

    Brennan, C. W.; Verhaak, R. G. W.; McKenna, A.; Campos, B.; Noushmehr, H.; Salama, S. R.; Zheng, S.; Chakravarty, D.; Sanborn, J. Z.; Berman, S. H.; more...
    Cell (2013)

    Fulltext@MSK | Save
  • Intratumoral heterogeneity of receptor tyrosine kinases EGFR and PDGFRA amplification in glioblastoma defines subpopulations with distinct growth factor response
    Journal Article

    Szerlip, N. J.; Pedraza, A.; Chakravarty, D.; Azim, M.; McGuire, J.; Fang, Y.; Ozawa, T.; Holland, E. C.; Huse, J. T.; Jhanwar, S.; more...
    Proceedings of the National Academy of Sciences of the United States of America (2012)

    Fulltext@MSK | Save
  • Small-molecule MAPK inhibitors restore radioiodine incorporation in mouse thyroid cancers with conditional BRAF activation
    Journal Article

    Chakravarty, D.; Santos, E.; Ryder, M.; Knauf, J. A.; Liao, X. H.; West, B. L.; Bollag, G.; Kolesnick, R.; Thin, T. H.; Rosen, N.; more...
    Journal of Clinical Investigation (2011)

    Fulltext@MSK | Save
  • Defining and targeting tumor signaling networks in Nf1 deficient glioblastoma
    Meeting Abstract

    Chakravarty, D.; Pedraza, A.; Koul, D.; Yung, W. K. A.; Brennan, C. W.
    Neuro-Oncology (2011)

    Fulltext@MSK | Save
  • Pharmacological therapy of mouse models of thyroid cancer induced by oncogenic effectors in the MAPK and PI3K pathways
    Meeting Abstract

    Fagin, J. A.; Franco, A.; Malaguarnera, R.; Ghossein, R.; Chakravarty, D.; Knauf, J. A.
    Cancer Research (2009)

    Fulltext@MSK | Save